New one-and-done therapy can help curb severe COVID-19 infection: Canadian-led study
A Canadian-led study of a new potential antiviral therapy shows a single dose can help cut the risk of hospitalization and death from COVID-19.
A Canadian-led study of a new potential antiviral therapy shows a single dose can help cut the risk of hospitalization and death from COVID-19.